Valuation

TGTXTG Therapeutics

StockNasdaqEstados UnidosHealth careEU retail: available

+0.1% today · +59.3% over a year

5/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 83% of the instruments we score

Trend: among the best of its peers; priced higher than most peers (P/E 18.9). No dividend.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricTGTXSector medianvs median
P/E18.928.8 · n=11435% below
P/B13.83.0 · n=197356% above
P/S10.43.8 · n=203177% above
EV/EBIT62.524.1 · n=103159% above
Free-cash-flow yield0.2%2.7% · n=18892% below
Dividend yield0.00%0.00% · n=216—
Return on equity100.3%2.4% · n=1944,071% above
Return on invested capital21.7%3.4% · n=177537% above
Gross margin82.4%62.5% · n=15232% above
Net debt / EBITDA1.421.19 · n=10819% above

Value factor: 39 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

InstrumentP/EP/BEV/EBITFree-cash-flow yieldDividend yieldSmart Score
LLYEli Lilly & Co42.633.6—1.6%0.6%6/10
JNJJohnson & Johnson29.17.2—3.6%2.1%8/10
ABBVAbbVie79.9—33.53.6%3.0%5/10
MRKMerck114.68.7—4.4%2.3%8/10
UNHUnitedHealth25.13.418.66.7%2.3%9/10
TMOThermo Fisher Scientific35.74.735.22.9%0.3%8/10
AMGNAmgen26.319.724.04.4%2.3%6/10
GILDGILEAD—16.1—6.8%2.1%4/10
ABTAbbott28.53.426.84.1%3.0%5/10
PFEPfizer38.42.0—6.6%5.9%1/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 jun 2026 · filed 05 ago 2026